FIRM FIXED PRICE

PINE PHARMACEUTICALS LLC - NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE

PIID: 75N94025F00003
Signed Date: Jan 16, 2026Effective Date: Aug 14, 2025End Date: Closed on May 31, 2026
Award $
$69K
Vendor
PINE PHARMACEUTICALS LLC
NAICS
325412
Signed Date
Jan 16, 2026

Key Details

Dollars Obligated
$69,466.32
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
COMPETED UNDER SAP
Place of Performance
TONAWANDA, NY, 141501001, CD-NY-26

Description

NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE

Context & Analysis

On Jan 16, 2026, Department of Health and Human Services obligated $69,466.32 to PINE PHARMACEUTICALS LLC for niddk: service: intravenous stable isotope glucose (6,6 deuterated glucose) for metabolic research. nonseverable. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap. Performance is located in TONAWANDA, NY.

Contractor Information

UEI: TCJXKNYD6WL5
CAGE Code: 7JZE9
Location: TONAWANDA, NY
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related